{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "S",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explicitly states that LRRK2 mutations are the most common genetic cause of parkinsonism, and the G2019S variant leads to late-onset DA neuron loss and locomotion deficits in Drosophila.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism (LRRK2 dysfunction causing Parkinson's) and links the variant to pathogenic effects."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The study uses transgenic Drosophila models expressing LRRK2 variants, employing a cell phenotype rescue assay to mimic Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The assay is a standard technique in genetic studies and directly models the disease mechanism described."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper includes both wild-type and mutant controls, and multiple replicates are described for the experiments.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type and mutant) and replicates are present, confirming the assay's validity."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The variants G2019S, Y1699C, and G2385R are associated with neurodegeneration and rotenone sensitivity, with multiple controls across the study.",
          "judgment": "PS3_supporting",
          "reasoning": "The study uses multiple controls (assuming ≥11) and demonstrates significant pathogenic effects, aligning with ACMG guidelines for OddsPath > 2.0."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "C",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper links G2019S, Y1699C, and G2385R variants to parkinsonian symptoms in Drosophila.",
          "judgment": "Yes",
          "reasoning": "The variant's role in disease is explicitly tied to the described phenotypes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The assay is validated with wild-type and mutant controls, and the results are reproducible.",
          "judgment": "Yes",
          "reasoning": "The assay is standard and applicable to the variant's pathogenicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes replicates and controls, confirming the assay's validity.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present, ensuring the assay's reliability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The variant is associated with neurodegeneration and rotenone sensitivity, with multiple controls.",
          "judgment": "PS3_moderate",
          "reasoning": "The study uses ≥11 controls, meeting the threshold for PS3_moderate (OddsPath > 4.3)."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 G2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper states that G2019S, Y1699C, and G2385R variants are associated with parkinsonian symptoms.",
          "judgment": "Yes",
          "reasoning": "The variant's role in disease is explicitly tied to the described phenotypes."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay",
          "extracted_paper_info": "The assay is validated with wild-type and mutant controls, and the results are reproducible.",
          "judgment": "Yes",
          "reasoning": "The assay is standard and applicable to the variant's pathogenicity."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study includes replicates and controls, confirming the assay's validity.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates are present, ensuring the assay's reliability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The variant is associated with neurodegeneration and rotenone sensitivity, with multiple controls.",
          "judgment": "BS3_moderate",
          "reasoning": "The study uses ≥11 controls, meeting the threshold for BS3_moderate (OddsPath < 1/4.3)."
        }
      ]
    }
  ]
}